发明名称 |
COMBINATIONS OF AKT INHIBITOR COMPOUNDS AND ABIRATERONE, AND METHODS OF USE |
摘要 |
The invention provides A combination of, a) a compound of Formula (I) or a pharmaceutically acceptable salt thereof; and b) erlotinib or a pharmaceutically acceptable salt thereof for the prophylactic or therapeutic treatment of a hyperproliferative disorder, such as cancer. |
申请公布号 |
KR20140082593(A) |
申请公布日期 |
2014.07.02 |
申请号 |
KR20137029063 |
申请日期 |
2012.03.30 |
申请人 |
GENENTECH, INC. |
发明人 |
NANNINI MICHELLE;SAMPATH DEEPAK |
分类号 |
A61K31/506;A61K31/497;A61K31/517;A61P35/00;C07D239/70;C07D403/04 |
主分类号 |
A61K31/506 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|